LISATA THERAPEUTICS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Lisata Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q3 2024.
  • Lisata Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Lisata Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$1.6M, a 4.44% decline year-over-year.
  • Lisata Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$2.33M, a 6.01% increase from 2022.
  • Lisata Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.48M, a 64.4% decline from 2021.
  • Lisata Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.51M, a 86.1% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.6M $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$1.6M $0 +$2.33M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$2.33M -$798K -$1.6M -200% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2024 $800K $0 0% Mar 4, 2024 10-Q 2024-11-12
Q4 2023 -$2.33M -$800K -$800K Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$1.53M $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$1.53M -$2.33M -$2.33M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $800K +$3.28M Apr 5, 2023 10-Q 2024-08-12
Q1 2023 $800K $0 +$2.48M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$2.48M $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$2.48M $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$2.48M $0 +$1.51M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$3.99M -$2.48M -$2.48M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$1.51M $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$1.51M +$9.36M +86.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$10.9M -$10.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q3 2019 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q4 2018 $0 $0 +$3.23M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$3.23M $0 +$2.41M Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$5.64M $0 +$5.89M Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$11.5M $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$11.5M -$3.23M -$3.17M -5943% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$8.35M -$2.41M -$2.41M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$5.94M -$5.89M -$5.89M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$53.4K $0 -$53.4K -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $0 -$53.4K +$13.6M +99.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-22
Q3 2016 -$13.6M $0 -$46.6K -100% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$13.5M $0 +$3.7M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$17.2M $53.4K +$6.75K +14.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$17.2M -$13.6M -$13.4M -5433% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$3.86M $46.6K -$754 -1.59% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$3.86M -$3.7M -$3.75M -7915% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$105K $46.6K -$776 -1.64% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$104K -$246K -$534K -186% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $430K $47.4K +$2.63K +5.88% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $427K $47.4K -$400K -89.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $828K $47.4K +$47.4K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $780K $288K +$463K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $317K $44.8K +$44.8K Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 $272K $448K +$448K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$176K $0 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$176K -$176K +$340K +65.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$515K $0 -$26.2K -100% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$489K $0 +$104K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$593K $0 -$593K -100% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $0 -$515K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-11
Q3 2011 $26.2K -$260K -90.9% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-10
Q2 2011 -$104K -$506K -126% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $593K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $286K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $402K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.